Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition by Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton Complete Edition || All Chapters Included|| 100% Verified Answers|| Latest Edition||

Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition By
Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton Complete

,Chapter 01: Drug Definitions, Standards, and Information Sources
A A A A A A A

Willihnganz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
A A A A A A A




MULTIPLEACHOICE

WhichAnameAidentifiesAaAdrugAlistedAbyAtheAUSAFoodAandA
DrugAAdministrationA(FDA)?
Brand
Nonproprietary
Official
Trademark
ANS:AC
TheAofficialAnameAisAtheAnameAunderAwhichAaAdrugAisAlistedA
byAtheAFDA.ATheAbrandAname,AorAtrademark,AisAtheAnameAgi
venAtoAaAdrugAbyAitsAmanufacturer.ATheAnonproprietary,AorAg
eneric,AnameAisAprovidedAbyAtheAUnitedAStatesAAdoptedANa
mesACouncil.

DIF: CognitiveALevel:AKnowledge REF:Ap.A9
OBJ:A1NAT:ANCLEXAClientANeedsACategory:ASafe,AEffectiveACare
EnvironmentATOP:AANursingAProcessAStep:AAssessment CON:
PatientAEducation

WhichAsourceAcontainsAinformationAspecificAtoAnutritionalAsupplements?
USPADictionaryAofAUSANA&AInternationalADrugANames
NaturalAMedicinesAComprehensiveADatabase
UnitedAStatesAPharmacopoeia/NationalAFormularyA(USPANF)
DrugAInteractionAFacts
ANS:AC
UnitedAStatesAPharmacopoeia/NationalAFormularyAcontainsAinformationAspecificAtoAnutrition
alAsupplements.AUSPADictionaryAofAUSANA&AInternationalADrugANamesAisAaAcompilationAofAd
rugAnames,ApronunciationAguide,AandApossibleAfutureAFDAAapprovedAdrugs;AitAdoesAnotAinclud
eAnutritionalAsupplements.ANaturalAMedicinesAComprehensiveADatabaseAcontainsAevidence-
basedAinformationAonAherbalAmedicinesAandAherbalAcombinationAproducts;AitAdoesAnotAinclude
AinformationAspecificAtoAnutritionalAsupplements.ADrugAInteractionAFactsAcontainsAcomprehen

siveAinformationAonAdrugAinteractionAfacts;AitAdoesAnotAincludeAnutritionalAsupplements.

DIF: CognitiveALevel:AKnowledge REF: p.A4 OBJ:A3
NAT:ANCLEXAClientANeedsACategory:APhysiologicalAIntegrity
TOP: NursingAProcessAStep:AAssessment CON:ANutritionA|APatientAEducation

WhichAdrugAreferenceAcontainsAdrugAmonographsAthatAdescribeAallAdrugsAinAaAtherapeuticAcla
ss?Aa.ADrugAFactsAandAComparisons

,TestABankAForAClayton’sABasicAPharmacologyAforANursesA19thAEdition 3

DrugAInteractionAFacts
HandbookAonAInjectableADrugs
Martindale—TheACompleteADrugAReference
ANS:AA
DrugAFactsAandAComparisonsAcontainsAdrugAmonographsAthatAdescribeAallAdrugsAinA
aAtherapeuticAclass.AMonographsAareAformattedAasAtablesAtoAallowAcomparisonAofAsi
milarAproducts,AbrandAnames,Amanufacturers,AcostAindices,AandAavailableAdosageAfor
msAOnlineAversionAisAavailable.

DIF: CognitiveALevel:AKnowledge REF:Ap.A4ATableA1.2
OBJ: 3 NAT:ANCLEXAClientANeedsACategory:APhysiologicalAIntegrity
CON:ASafetyA|APatientAEducationA|AClinicalAJudgme
TOP: NursingAProcessAStep:AAssessment nt

WhichAdrugAreferenceAcontainsAmonographsAaboutAvirtuallyAeveryAsingle-
entityAdrugAavailableAinAtheAUnitedAStatesAandAdescribesAtherapeuticAusesAofAdrugs,Aincludin
gAapprovedAandAunapprovedAuses?
Martindale:ATheACompleteADrugAReference
AHFSADrugAInformation
DrugAReference
DrugAFactsAandAComparisons
ANS:AB
AHFSADrugAInformationAcontainsAmonographsAaboutAvirtuallyAeveryAsingle-
entityAdrugAavailableAinAtheAUnitedAStatesAandAdescribesAtherapeuticAusesAofAdrugs,Aincluding
AapprovedAandAunapprovedAuses.




DIF: CognitiveALevel:AKnowledge REF:Ap.A4ATableA1.2
OBJ: 3 NAT:ANCLEXAClientANeedsACategory:APhysiologicalAIntegrity
CON:ASafetyA|APatientAEducationA|AClinicalAJudgme
TOP: NursingAProcessAStep:APlanning nt

WhichAonlineAdrugAreferenceAmakesAavailableAtoAhealthcareAprovidersAandAtheApublicAaAstand
ard,Acomprehensive,Aup-to-dateAlookAupAandAdownloadableAresourceAaboutAmedicines?
AmericanADrugAIndex
AmericanAHospitalAFormulary
DailyMed
DrugAReference
ANS:AC
DailyMedAmakesAavailableAtoAhealthcareAprovidersAandAtheApublicAaAstandard,Acomprehensiv
e,Aup-to-
dateAlookAupAandAdownloadableAresourceAaboutAmedicines.ATheAAmericanADrugAIndexAisAnot
AappropriateAforApatientAuse.ATheAAmericanAHospitalAFormularyAisAnotAappropriateAforApatie

ntAuse.ATheAdrugAreferenceAisAnotAappropriateAforApatientAuse.

DIF: CognitiveALevel:AKnowledge REF: p.A3A|Ap.A4 OBJ:A3
NAT:ANCLEXAClientANeedsACategory:APhysiologicalAIntegrity
TOP:ANursingAProcessAStep:AImplementation
CON:ASafetyA|APatientAEducationA|AClinicalAJudgment

WhichAlegislationAauthorizesAtheAFDAAtoAdetermineAtheAsafetyAofAaAdrugAbeforeAitsAmarketing?
FederalAFood,ADrug,AandACosmeticAActA(1938)
DurhamAHumphreyAAmendmentA(1952)

, TestABankAForAClayton’sABasicAPharmacologyAforANursesA19thAEdition 4

ControlledASubstancesAActA(1970)
KefauverAHarrisADrugAAmendmentA(1962)
ANS:AA
TheAFederalAFood,ADrug,AandACosmeticAActAofA1938AauthorizedAtheAFDAAtoAdetermineAtheAsa
fetyAofAallAdrugsAbeforeAmarketing.ALaterAamendmentsAandAactsAhelpedAtightenAFDAAcontrolAa
ndAensureAdrugAsafety.ATheADurhamAHumphreyAAmendmentAdefinesAtheAkindsAofAdrugsAthatA
cannotAbeAusedAsafelyAwithoutAmedicalAsupervisionAandArestrictsAtheirAsaleAtoAprescriptionAbyA
aAlicensedApractitioner.ATheAControlledASubstancesAActAaddressesAonlyAcontrolledAsubstancesA
andAtheirAcategorization.ATheAKefauverAHarrisADrugAAmendmentAensuresAdrugAefficacyAandAg
reaterAdrugAsafety.ADrugAmanufacturersAareArequiredAtoAproveAtoAtheAFDAAtheAeffectivenessAo
fAtheirAproductsAbeforeAmarketingAthem.

DIF: CognitiveALevel:AKnowledge REF:AAp.A5ATableAl.3
OBJ: 5 NAT:ANCLEXAClientANeedsACategory:APhysiologicalAIntegrity
TOP:ANursingAProcessAStep:AAssessment
CON:ASafetyA|APatientAEducationA|AEvidenceA|AHealthACareALaw

WhichAclassificationAdoesAmeperidineA(Demerol)AfallAunder?
I
II
III
IV
ANS:AB
MeperidineA(Demerol)AisAaAScheduleAIIAdrug;AitAhasAaAhighApotentialAforAabuseAandAmayAleadA
toAsevereApsychologicalAandAphysicalAdependence.AScheduleAIAdrugsAhaveAhighApotentialAforA
abuseAandAnoArecognizedAmedicalAuse.AScheduleAIIIAdrugsAhaveAsomeApotentialAforAabuse.AUs
eAmayAleadAtoAlowAtoAmoderateAphysicalAdependenceAorAhighApsychologicalAdependence.ASch
eduleAIVAdrugsAhaveAlowApotentialAforAabuse.AUseAmayAleadAtoAlimitedAphysicalAorApsycholog
icalAdependence.

DIF: CognitiveALevel:AKnowledge REF: p.A10 OBJ:A2
NAT:ANCLEXAClientANeedsACategory:ASafe,AEffectiveACareAEnvironment
TOP: NursingAProcessAStep:AAssessment CON:APatientAEducationA|AAddictionA|APain

WhichAactionAwouldAtheAFDAAtakeAtoAexpediteAdrugAdevelopmentAandAapprovalAforAanAoutbr
eakAofAsmallpox?
ListAsmallpoxAasAaAhealthAorphanAdisease.
OmitAtheApreclinicalAresearchAphase.
ExtendAtheAclinicalAresearchAphase.
FastAtrackAtheAinvestigationalAdrug.
ANS:AD
OnceAtheAInvestigationalANewADrugAApplicationAhasAbeenAapproved,AtheAdrugAcanAreceiveAhi
ghestApriorityAwithinAtheAagency,AwhichAisAcalledAfastAtracking.AAAsmallpoxAoutbreakAwouldA
becomeAaApriorityAconcernAinAtheAworld.AOrphanAdiseasesAareAnotAresearchedAinAaApriorityAma
nner.APreclinicalAresearchAisAnotAomitted.AExtendingAanyAphaseAofAtheAresearchAwouldAmeanA
aAlongerAtimeAtoAdevelopAaAvaccine.ATheAFDAAmustAensureAthatAallAphasesAofAtheApreclinicalA
andAclinicalAresearchAphaseAhaveAbeenAcompletedAinAaAsafeAmanner.

DIF: CognitiveALevel:AKnowledge REF: p.A7 OBJ:A5